Cargando…
A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer
BACKGROUND: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to infor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768835/ https://www.ncbi.nlm.nih.gov/pubmed/33356632 http://dx.doi.org/10.1177/1534735420983472 |
_version_ | 1783629218759835648 |
---|---|
author | Conte, Ellen Legacy, Mark Psihogios, Athanasios Pitman, Anne Redway, Andrea Hamer-Wilson, Jill Seely, Dugald |
author_facet | Conte, Ellen Legacy, Mark Psihogios, Athanasios Pitman, Anne Redway, Andrea Hamer-Wilson, Jill Seely, Dugald |
author_sort | Conte, Ellen |
collection | PubMed |
description | BACKGROUND: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program. OBJECTIVES: (1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications. METHODS: Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy – Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes. RESULTS: The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (−1.2, 95% CI −2.0 to −0.4) and overall wellbeing (−0.9, 95% CI −2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from −1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued. CONCLUSIONS: The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned. |
format | Online Article Text |
id | pubmed-7768835 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-77688352021-01-21 A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer Conte, Ellen Legacy, Mark Psihogios, Athanasios Pitman, Anne Redway, Andrea Hamer-Wilson, Jill Seely, Dugald Integr Cancer Ther 20 Years of Integrative Cancer Therapies BACKGROUND: Lung cancer is the leading cause of cancer mortality in Canada, yet patients are often under-supported. A six-week program called Inspire Now, created to address unmet supportive care needs, was evaluated in this study. Feasibility and preliminary outcomes were assessed in order to inform future changes to the program. OBJECTIVES: (1) Assess the feasibility of the program and its evaluation; (2) pilot the collection of patient-reported outcomes; (3) identify outcomes that may be positively influenced; and (4) inform program modifications. METHODS: Participants were recruited from the first session of Inspire Now for an observational pilot study. The primary outcome was feasibility. Secondary outcomes included within-person changes in Functional Assessment of Cancer Therapy – Lung (FACT-L) and Measure Yourself Concerns and Wellbeing (MYCaW), and program satisfaction and qualitative experiences of participants and facilitators through internally-developed questionnaires and semi-structured interviews. Analysis was primarily descriptive, within person changes in FACT-L and MYCaW were analyzed using the Wilcoxon signed-rank test and qualitative data was assessed for common themes. RESULTS: The program and its evaluation were feasible; 8 of 9 (89%) participants consented to the study, median attendance was 6 of 6 sessions (IQR 4.5-6), and questionnaire completion was 100% at baseline and 75% at follow-up. There were clinically meaningful improvements in MYCaW concern 1 (−1.2, 95% CI −2.0 to −0.4) and overall wellbeing (−0.9, 95% CI −2.1 to 0.4). Seven of eight FACT-L sub-sections trended toward improvement, with absolute changes ranging from −1.7 to 10.8%. Participant feedback was overwhelmingly positive; group support and social interactions were highly valued. CONCLUSIONS: The group intervention for people with lung cancer was feasible to both run and evaluate. Participants responded positively to the program. Findings will inform changes to future sessions and an analysis of multiple sessions is planned. SAGE Publications 2020-12-24 /pmc/articles/PMC7768835/ /pubmed/33356632 http://dx.doi.org/10.1177/1534735420983472 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | 20 Years of Integrative Cancer Therapies Conte, Ellen Legacy, Mark Psihogios, Athanasios Pitman, Anne Redway, Andrea Hamer-Wilson, Jill Seely, Dugald A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer |
title | A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer |
title_full | A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer |
title_fullStr | A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer |
title_full_unstemmed | A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer |
title_short | A Prospective Outcomes Pilot Evaluation of Inspire Now: A Program for People with Lung Cancer |
title_sort | prospective outcomes pilot evaluation of inspire now: a program for people with lung cancer |
topic | 20 Years of Integrative Cancer Therapies |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768835/ https://www.ncbi.nlm.nih.gov/pubmed/33356632 http://dx.doi.org/10.1177/1534735420983472 |
work_keys_str_mv | AT conteellen aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT legacymark aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT psihogiosathanasios aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT pitmananne aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT redwayandrea aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT hamerwilsonjill aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT seelydugald aprospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT conteellen prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT legacymark prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT psihogiosathanasios prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT pitmananne prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT redwayandrea prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT hamerwilsonjill prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer AT seelydugald prospectiveoutcomespilotevaluationofinspirenowaprogramforpeoplewithlungcancer |